In most cancers, NRP1 and NRP2 expression was found to be positively correlated with immune checkpoint genes (CD274, CTLA4, HAVCR2, LAG3, PDCD1, PDCD1LG2, SIGLEC15, and TIGIT) (Figures 5(a) and 5(b)). Here, LAG3 is linked to cancer.